Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva reports preliminary financial results for Full-Year 2022¹
Investegate announcements from ,
Source: investegate.co.uk
Page 9 - Global External News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Global External. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Global External Today - Breaking & Trending Today
Investegate |INVENTIVA Announcements | INVENTIVA: Correction: Inventiva reports preliminary financial results for Full-Year 2022¹
Investegate announcements from INVENTIVA, Correction: Inventiva reports preliminary financial results for Full-Year 2022¹
Source: investegate.co.uk
INVENTIVA: Inventiva announces changes to the clinical development of lanifibranor, including plans for a new Phase III trial in patients with NASH and compensated cirrhosis
Proposed changes are expected to be beneficial to the lanifibranor clinical program by reducing the number of biopsies and the trial duration, eventually offering all patients in the trial access to treatment
Source: finanznachrichten.de
Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva announces changes to the clinical development of lanifibranor, including plans for a new Phase III trial in patients with NASH and compensated cirrhosis
Investegate announcements from INVENTIVA, Inventiva announces changes to the clinical development of lanifibranor, including plans for a new Phase III trial in patients with NASH and compensated cirrhosis
Source: investegate.co.uk
Investegate |INVENTIVA Announcements | INVENTIVA: Inventiva secures a new patent expanding the IP protection of its lead product candidate lanifibranor in the US
Investegate announcements from INVENTIVA, Inventiva secures a new patent expanding the IP protection of its lead product candidate lanifibranor in the US
Source: investegate.co.uk